CSRXP: BIG PHARMA DOUBLES DOWN ON EGREGIOUS PRICE HIKES OUTPACING INFLATION
Dec 14, 2023
Administration Announces Drug Makers Increased Prices Faster Than Rate of… Read More
© 2024 CSRXP- All Rights Reserved
Updates
FACT SHEET: BIG PHARMA BRINGS INSULIN PRICE-GOUGING PLAYBOOK TO BLOCKBUSTER WEIGHT LOSS DRUGS
Dec 13, 2023
Big Pharma Eyeing Egregious Price Tags, Aggressive Marketing to Push GLP-1s… Read More
DOSE OF REALITY: BIG PHARMA’S INNOVATION TAP DANCE HAS INDUSTRY TRIPPING OVER ITS OWN RHETORIC
Dec 12, 2023
Big Pharma Continues Pushing Myth That Solutions to Lower Rx Prices Will… Read More
BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST EIGHT BRAND NAME DRUGS COST U.S. $1.2 BILLION IN 2022
Dec 11, 2023
New Analysis Showcases How Big Pharma Raises Prices on Blockbuster Products… Read More
SECOND OPINION: THE RELATIONSHIP BETWEEN BIG PHARMA’S PRICE-GOUGING AND BLOCKBUSTER SPENDING ON DIRECT-TO-CONSUMER ADVERTISING
Dec 8, 2023
Greater List Price Transparency Will Help Deter Big Pharma’s Egregious… Read More
DOSE OF REALITY: VOTERS WANT CANDIDATES TALKING ABOUT DRUG PRICES AND FOCUSED ON HOLDING BIG PHARMA ACCOUNTABLE
Dec 6, 2023
KFF Survey Finds Americans Want White House Contenders Talking Rx Prices,… Read More
BIG PHARMA WATCH: PHARMA PATENTS INVALIDATED MORE THAN ANY OTHER INDUSTRY FOR MISREPRESENTED OR OMITTED INFORMATION
Nov 17, 2023
Analysis Finds Bogus and Faulty Patents Contribute to Rising Prescription Drug… Read More
BIG PHARMA EARNINGS WATCH: ELI LILLY, GLAXOSMITHKLINE AND ASTRAZENECA
Nov 14, 2023
Another Blockbuster Quarter for Profits as Big Pharma Maintains… Read More
SECOND OPINION: NUMBER OF CANCER DRUGS IN DEVELOPMENT CLIMBS DESPITE PHRMA CLAIM DRUG PRICING SOLUTIONS WOULD UNDERMINE ONCOLOGY INNOVATION
Nov 10, 2023
PhRMA Undercuts Own Rhetoric by Showing the Cancer Drug Pipeline is Growing… Read More
CSRXP APPLAUDS FTC CRACKDOWN ON BIG PHARMA’S FLAGRANT ABUSE OF THE PATENT SYSTEM
Nov 7, 2023
Commission Targets More Than 100 Patents on Brand Name Products Listed in the… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE AND AMGEN
Nov 3, 2023
Another Series of Strong Earnings Reports For Brand Name Giants Fueled by… Read More
ICYMI: CSRxP JOINS MORE THAN 50 ORGANIZATIONS CALLING ON THE U.S. SENATE TO PASS BIPARTISAN SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Nov 2, 2023
Broad-based Coalition of Advocates, Including AARP and Patients for Affordable… Read More